The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 08, 2025

Filed:

Feb. 05, 2024
Applicant:

Larimar Therapeutics, Inc., Bala Cynwyd, PA (US);

Inventors:

Joan David Bettoun, Elkins Park, PA (US);

Rebecca Wissner, Wayne, PA (US);

Assignee:

Larimar Therapeutics, Inc., Bala Cynwyd, PA (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 14/47 (2006.01); A61K 38/00 (2006.01); A61K 47/64 (2017.01); A61P 25/00 (2006.01); A61P 25/16 (2006.01); A61P 25/28 (2006.01); C07K 14/005 (2006.01); C12N 9/02 (2006.01); C12N 9/10 (2006.01);
U.S. Cl.
CPC ...
C07K 14/47 (2013.01); A61K 47/64 (2017.08); C07K 14/005 (2013.01); C12N 9/104 (2013.01); C12Y 203/02 (2013.01); A61K 38/00 (2013.01); C07K 2319/02 (2013.01); C07K 2319/07 (2013.01); C07K 2319/50 (2013.01); C12N 2740/16322 (2013.01);
Abstract

The present disclosure provides a fusion protein useful for treating a non-nuclear organelle associated disorder, such as a genetic disorder, e.g., Friedrich's Ataxia. The fusion protein may comprise a protein of interest to be delivered to a non-nuclear organelle; an organelle targeting sequence (OTS); a cell penetrating peptide (CPP); and a target enhancing sequence (TES); wherein the CPP is capable of interference with delivery of the protein of interest to the non-nuclear organelle; and wherein the TES prevents interference by the CPP. The fusion protein may also comprise a protein of interest to be delivered to a non-nuclear organelle; a CPP and a TES. The present disclosure also provides methods for treating a non-nuclear organelle associated disorder by administering the fusion protein to a subject in need thereof.


Find Patent Forward Citations

Bettoun, Joan. (2025). Molecules for organelle-specific protein delivery (U.S. Patent No. 12351611). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12351611

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…